Ethical And Legal Implications Of Prescribing Drugs 145913

Ethical And Legal Implications Of Prescribing Drugs

A 2-3 page analysis on the ethical and legal implications of prescribing medications, specifically examining the scenario of a medication error leading to a life-altering condition in an elderly patient. The discussion includes the impact on all stakeholders involved, strategies for disclosure and nondisclosure in compliance with Illinois state laws, the decision-making process for advanced practice nurses regarding error disclosure, the prescription writing process with error minimization strategies, and concludes with an overview of ethical considerations and professional responsibilities.

Paper For Above instruction

The ethical and legal implications of prescribing drugs encompass complex considerations involving multiple stakeholders—including prescribers, pharmacists, patients, and their families—particularly in scenarios of medication errors that result in adverse outcomes. These implications are rooted in foundational principles of medical ethics, such as beneficence, non-maleficence, autonomy, and justice, as well as legal statutes that regulate prescribing practices.

In the specific case of Ac, the 72-year-old male suffering a massive stroke due to a medication error, the ethical dilemmas primarily revolve around disclosure and patient autonomy. The prescriber and healthcare team are faced with the challenge of balancing transparency with legal obligations, especially considering the absence of advanced directives. Ethically, honesty in disclosure upholds the patient's right to know and facilitates shared decision-making, while nondisclosure could potentially avoid distress but may violate the ethical tenets of truthfulness and respect for autonomy. Legally, Illinois law mandates that healthcare providers disclose medical errors that result in harm, emphasizing transparency and patient rights. The Illinois Duty to Warn and its specific regulations necessitate that practitioners inform patients or surrogates about adverse events and errors, supporting the ethical imperative of honesty with legal backing.

The patient's family members—his wife and daughter—are also impacted. The wife believes her husband would not want to live in this unresponsive state, indicating the importance of respecting patient autonomy and previously expressed wishes. Conversely, the daughter’s stance reflects a more cautious approach, emphasizing the complexity of surrogate decision-making. Healthcare providers must navigate these familial perspectives ethically by engaging in open, compassionate communication and, when possible, considering the patient's values and preferences even in absence of formal directives.

To address issues of disclosure and nondisclosure, strategies must be aligned with Illinois laws that emphasize honesty and accountability. Transparent disclosure involves promptly informing the patient or surrogate about the medication error, the nature of the harm, and the steps being taken to address the situation. Documentation of all disclosures is critical for legal protection. In cases where nondisclosure is considered, it must be justified by legal or ethical grounds—such as potential harm from disclosure or the patient's best interest—though generally, transparency aligns with legal mandates. Engaging institutional policies and ethics consultations can assist clinicians in navigating these sensitive disclosures.

Advanced practice nurses (APNs) play a pivotal role in decision-making within such scenarios. Two strategies to guide ethical decision-making include adhering to the principles of honesty and accountability, and utilizing ethics consults. Honesty ensures that the nurse discloses errors in a manner consistent with legal and ethical standards, which fosters trust and supports patient-centered care. Accountability involves taking responsibility for actions and participating in organizational error-reporting systems to prevent future incidents. As an APN, I would advocate for disclosing the error to the family, justified by the ethical imperative for truth-telling and legal requirements under Illinois law. Disclosing the error, despite potential personal or professional discomfort, aligns with the moral obligation to prioritize patient safety and uphold professional integrity.

The process of writing prescriptions is a critical component of medication management that requires precision and awareness of strategies to minimize errors. Typically, prescription writing involves documenting the patient's identification, medication name, dose, route, frequency, and duration, along with prescriber credentials. Using legible handwriting or electronic prescribing reduces misinterpretation. Incorporating decision support systems, such as drug interaction alerts and standardized abbreviations, also minimizes errors. For example, avoiding error-prone abbreviations like "U" for units or "QD" for once daily reduces miscommunication. Moreover, verifying patient allergies and current medications ensures safe prescribing practices. Regular training and adherence to formulary guidelines further enhance safety.

In conclusion, the ethical and legal considerations surrounding prescribing medications demand vigilant adherence to principles of transparency, beneficence, and justice, especially in adverse situations like medication errors. For healthcare professionals, particularly advanced practice nurses, it is essential to foster trust through honest communication, guided by legal statutes such as Illinois law, and organizational policies. Implementing diligent prescription writing practices with error mitigation strategies like electronic systems and clear documentation reduces risks. Ultimately, maintaining ethical integrity and legal compliance benefits patients, families, and the healthcare system as a whole, reinforcing the commitment to safe, compassionate, and ethical clinical practice.

References

• Rosenthal, L. D., & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.). Elsevier.
• American Geriatrics Society 2019 Beers Criteria Update Expert Panel. (2019). American Geriatrics Society 2019 updated AGS Beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 67(4), 674–694. https://doi.org/10.1111/jgs.15767
• Drug Enforcement Administration. (2021). CFR - Code of Federal Regulations Title 21. https://www.ecfr.gov/current/title-21
• Institute for Safe Medication Practices. (2017). List of error-prone abbreviations, symbols, and dose designations. https://www.ismp.org/resources/error-prone-abbreviations
• Sabatino, J. A., et al. (2017). Improving prescribing practices: A pharmacist-led educational intervention for nurse practitioner students. Journal of the American Association of Nurse Practitioners, 29(5), 248–254. https://doi.org/10.1002/.12446
• Illinois Nurse Practice Act. (2020). Illinois Compiled Statutes (225 ILCS 65). Retrieved from https://www.ilga.gov/legislation/ilcs/ilcs3.asp?ActID=2723
• American Nurses Association. (2015). Nursing: Scope and standards of practice. ANA.
• O’Connor, S. J., et al. (2018). Ethical decision-making in nursing practice. Relational ethics and dilemmas. Nursing Ethics, 25(5), 632–645.
• Jongen, C., et al. (2018). Legal and ethical considerations in medication management. Pharmacology & Therapeutics, 182, 19–26.
• Gartrell, D. (2014). A guidance approach for the encouraging classroom (6th ed.). Boston, MA: Cengage Learning.